ArticleEuropean journal of haematology2026
Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia.
Yu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.